Nicholas Company’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.84M Sell
204,595
-910
-0.4% -$31.1K 0.11% 158
2025
Q4
$8.13M Buy
205,505
+12,870
+7% +$472K 0.14% 131
2025
Q3
$6.79M Hold
192,635
0.12% 158
2025
Q2
$6.31M Buy
192,635
+15,135
+9% +$492K 0.11% 167
2025
Q1
$5.73M Hold
177,500
0.1% 178
2024
Q4
$5.42M Hold
177,500
0.09% 192
2024
Q3
$4.98M Buy
177,500
+80
+0% +$1.97K 0.08% 192
2024
Q2
$4.04M Hold
177,420
0.07% 203
2024
Q1
$5.4M Buy
177,420
+6,600
+4% +$221K 0.09% 189
2023
Q4
$6.1M Buy
170,820
+23,195
+16% +$863K 0.11% 177
2023
Q3
$6.47M Buy
147,625
+20
+0% +$976 0.13% 157
2023
Q2
$7.29M Hold
147,605
0.14% 151
2023
Q1
$6.12M Buy
147,605
+5,130
+4% +$213K 0.12% 174
2022
Q4
$6.32M Sell
142,475
-32,565
-19% -$1.36M 0.14% 162
2022
Q3
$6.84M Buy
175,040
+30,465
+21% +$1.39M 0.16% 144
2022
Q2
$5.91M Buy
144,575
+29,575
+26% +$1.4M 0.13% 178
2022
Q1
$7.55M Buy
115,000
+17,190
+18% +$1.11M 0.13% 170
2021
Q4
$6.8M Buy
+97,810
New +$7.11M 0.11% 199

Other funds holding ATRC